SecBot SecBot
DEFA14A ·Filed Apr 24, 2026

CRBU

Caribou Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001619856-26-000023
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the voting results for any unexpected opposition to director elections or auditor ratification, which could indicate shareholder concerns. Otherwise, this is a standard annual meeting with no immediate financial implications.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$2.13
T+0 close · Apr 24, 2026 · via day close
Latest settled
−22.07%
T+60 · $1.66
Vs SPY
−26.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 27 $2.13entry
  2. T+1 · 7mo ago −2.35%α −1.86% · $2.08
  3. T+5 · 7mo ago −10.33%α −10.73% · $1.91
  4. T+20 · 6mo ago +1.41%α −3.55% · $2.16
  5. T+60 · 4mo ago −22.07%α −26.84% · $1.66
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Caribou Biosciences is holding its 2026 annual meeting where shareholders will vote on electing three Class II directors, ratifying Deloitte & Touche LLP as auditors, approving an amendment to exculpate officers from certain fiduciary duties, and adjourning the meeting if needed. This is a routine annual shareholder meeting with no material financial impact.

Key Financial Metrics

Vote
director election
Meeting
2026-06-17

Key Facts

  • Election of three Class II directors: Andrew Guggenhime, David Johnson, and Nancy Whiting
  • Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026
  • Approval of amendment to provide for exculpation of officers from certain breaches of fiduciary duty
  • Approval of adjourning the 2026 Annual Meeting if necessary for further solicitation of proxies

Financial Impact

No direct financial impact from these proposals

Risk Factors

  • Potential shareholder opposition to officer exculpation amendment
  • Unexpected vote against auditor ratification could signal governance concerns

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001619856-26-000023
Document: 0001619856-26-000023-index-headers.html0001619856-26-000023
Document: 0001619856-26-000023-index.html0001619856-26-000023
Document: 0001619856-26-000023.txt0001619856-26-000023

Track record

13 reports on CRBU

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +28.02% at T+20 after the Oct 6, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 7/10 Entry $0.4487 Now $0.3530 +21.33% settles Dec 7
  2. Oct 6, 20265w ago 8-K Bearish 7/10 Entry $0.6174 to $0.4444 Now $0.3530 +42.82% ▲ +28.02% +26.68% vs SPY
  3. Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $1.34 to $0.5190 Now $0.3530 −73.66% ▼ −61.27% −60.71% vs SPY
  4. Jun 11, 202622w ago 8-K Bullish 6/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
  5. Jun 11, 202622w ago Press Release Bullish 7/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
  6. Jun 5, 202623w ago DEFA14A Neutral 2/10 Entry $1.84 to $1.83 Now $0.3530 −80.82% ▼ −0.54% −2.17% vs SPY
  7. Apr 24, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $2.13 to $2.16 Now $0.3530 −83.43% ▲ +1.41% −3.55% vs SPY
  8. Mar 5, 202636w ago 8-K Mixed 5/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
  9. Mar 5, 202636w ago Press Release Mixed 6/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
  10. Feb 28, 202637w ago Institutional Cluster Neutral 5/10 Entry $1.84 to $1.72 Now $0.3530 −80.82% ▼ −6.52% +1.42% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026